MRIGlobal, a health innovation company based in Kansas City, Missouri, is credited with helping to return 14 U.S. citizens who tested positive for COVID-19 back to U.S. soil. The company’s innovative biocontainment system was key in bringing them home safely for medical treatment.
MRIGlobal engineers originally developed the systems to combat the Ebola virus outbreak in 2014. The units are state-of-the-art, flight-ready containerized biocontainment systems (CBCS) that roll on and off planes. MRIGlobal designed the CBCS as a reusable biocontainment and medical treatment unit to operate on government/civilian cargo aircraft. The units can containerize highly contagious pathogens, are extremely durable and allow for the safe transport of critically ill patients while maintaining biocontainment and safe flight.
“We’re proud to play a part in helping to safely evacuate people out of harm’s way to locations where they can receive appropriate medical care,” said Dean Gray, Ph.D., Director at MRIGlobal. “There’s nothing like the CBCS for flyable medical transport. It was developed to respond to critical global health situations like the coronavirus outbreak, and ultimately to save lives.”